MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets cancer spread to the brain
Disease control Not yet recruitingThis study is testing a combination of three drugs (utidelone, bevacizumab, and sometimes etoposide) to treat cancer that has spread to the brain from lung or breast tumors. It will involve 56 patients to see if this approach can shrink brain tumors and control the disease. The g…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test One-Shot cancer drug combo in Early-Stage trial
Knowledge-focused Not yet recruitingThis is a very early, small study to see if a single dose of two immunotherapy drugs can change the immune cells inside certain stomach and esophageal tumors. It will involve 34 adults with early-stage cancer who have a specific genetic change (ARID1A mutation) and have not had a…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC